Dietary chalcones with chemopreventive and chemotherapeutic potential
Authors:
- 4 February 2011
- journal article
- research article
- Published by Springer Nature in Genes & Nutrition
- Vol. 6 (2) , 125-147
Abstract
Chalcones are absorbed in the daily diet and appear to be promising cancer chemopreventive agents. Chalcones represent an important group of the polyphenolic family, which includes a large number of naturally occurring molecules. This family possesses an interesting spectrum of biological activities, including antioxidative, antibacterial, anti-inflammatory, anticancer, cytotoxic, and immunosuppressive potential. Compounds of this family have been shown to interfere with each step of carcinogenesis, including initiation, promotion and progression. Moreover, numerous compounds from the family of dietary chalcones appear to show activity against cancer cells, suggesting that these molecules or their derivatives may be considered as potential anticancer drugs. This review will focus primarily on prominent members of the chalcone family with an 1,3-diphenyl-2-propenon core structure. Specifically, the inhibitory effects of these compounds on the different steps of carcinogenesis that reveal interesting chemopreventive and chemotherapeutic potential will be discussed.Keywords
This publication has 190 references indexed in Scilit:
- Flavokawain B, a kava chalcone, induces apoptosis via up‐regulation of death‐receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growthInternational Journal of Cancer, 2010
- Flavokawain B, a novel chalcone from Alpinia pricei Hayata with potent apoptotic activity: Involvement of ROS and GADD153 upstream of mitochondria-dependent apoptosis in HCT116 cellsFree Radical Biology and Medicine, 2010
- A boronic acid chalcone analog of combretastatin A-4 as a potent anti-proliferation agentBioorganic & Medicinal Chemistry, 2010
- Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative #Hepatology, 2009
- KB-34, a newly synthesized chalcone derivative, inhibits lipopolysaccharide-stimulated nitric oxide production in RAW 264.7 macrophages via heme oxygenase-1 induction and blockade of activator protein-1European Journal of Pharmacology, 2009
- Combination of isoliquiritigenin and tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in colon cancer HT29 cellsEnvironmental Health and Preventive Medicine, 2008
- TRAIL receptor-targeted therapeutics: Resistance mechanisms and strategies to avoid themDrug Resistance Updates, 2008
- Beer constituents as potential cancer chemopreventive agentsEuropean Journal of Cancer, 2005
- The plant polyphenol butein inhibits testosterone-induced proliferation in breast cancer cells expressing aromataseLife Sciences, 2005
- Role of nuclear factor‐κB and heme oxygenase‐1 in the mechanism of action of an anti‐inflammatory chalcone derivative in RAW 264.7 cellsBritish Journal of Pharmacology, 2004